Glucovance 500mg/2.5mg Tablets – Metformin & Glibenclamide for Type 2 Diabetes Control

Drug Class: Biguanide + Sulfonylurea Combination Antidiabetic | Form: Oral Tablet | Prescription Status: Prescription Only (Rx)

What Is Glucovance 500mg/2.5mg?

Glucovance 500mg/2.5mg is a prescription fixed-dose combination antidiabetic tablet containing Metformin Hydrochloride 500mg and Glibenclamide 2.5mg — the standard step-up strength used when blood sugar control remains inadequate on the initiation dose of Glucovance 250mg/1.25mg, or as the starting combination dose for patients transitioning directly from separate Metformin and Glibenclamide tablets at equivalent doses. Each tablet contains double the Metformin and double the Glibenclamide of the 250mg/1.25mg strength — delivering meaningfully stronger dual-mechanism blood sugar control while remaining at a moderate, well-tolerated Glibenclamide dose that balances efficacy with hypoglycaemia risk.

The two active ingredients work through completely different and complementary mechanisms — Metformin 500mg reduces the liver's excessive glucose production and improves the body's sensitivity to its own insulin without stimulating additional insulin secretion, while Glibenclamide 2.5mg directly stimulates the pancreatic beta cells to release more insulin in response to meals. Together they address the three core defects of type 2 diabetes — hepatic glucose overproduction, peripheral insulin resistance, and inadequate pancreatic insulin response — simultaneously in a single convenient twice-daily tablet.

Glucovance 500mg/2.5mg must always be taken with meals and used alongside dietary management and regular physical activity.

What Is Glucovance 500mg/2.5mg Used For?

Glucovance 500mg/2.5mg is prescribed for:

• Type 2 Diabetes Mellitus (ذیابیطس — شوگر) — as adjunct to diet and exercise for patients whose blood sugar and HbA1c remain above target on a single antidiabetic agent alone
• Step-up from Glucovance 250mg/1.25mg — for patients who have tolerated the initiation dose but require stronger dual-agent blood sugar control to achieve glycaemic targets
• Replacement of separate Metformin 500mg and Glibenclamide 2.5mg tablets — simplifying a two-tablet regimen into a single fixed-dose combination for improved adherence and convenience
• Patients inadequately controlled on Metformin alone — adding Glibenclamide's insulin secretagogue effect to existing Metformin therapy addresses the progressive beta cell failure component of type 2 diabetes
• Patients inadequately controlled on a sulfonylurea alone — adding Metformin's insulin-sensitising and hepatic glucose-suppressing action to existing sulfonylurea therapy

Glucovance 500mg/2.5mg is not suitable for Type 1 Diabetes, diabetic ketoacidosis, or as initial antidiabetic therapy in treatment-naive patients. It is a combination step-up therapy for inadequately controlled Type 2 Diabetes.

How Does Glucovance 500mg/2.5mg Work?

Metformin Hydrochloride 500mg — Insulin Sensitiser and Hepatic Glucose Suppressor: At 500mg — the standard full therapeutic Metformin dose per tablet — Metformin activates AMPK in liver cells, potently suppressing hepatic gluconeogenesis and glycogenolysis — reducing the liver's excessive glucose output that drives elevated fasting blood glucose in type 2 diabetes. Simultaneously, it improves the sensitivity of peripheral tissues — particularly skeletal muscle — to insulin, allowing more efficient glucose uptake from the bloodstream. The 500mg dose provides significantly stronger Metformin activity than the 250mg in the initiation strength — contributing greater fasting glucose reduction and insulin-sensitising benefit. Metformin does not stimulate insulin secretion and does not independently cause hypoglycaemia — any hypoglycaemia risk in Glucovance comes entirely from the Glibenclamide component.

Glibenclamide 2.5mg — Pancreatic Insulin Secretion Stimulator: At 2.5mg — double the initiation dose — Glibenclamide produces stronger and more sustained stimulation of pancreatic beta cell insulin secretion. By binding to ATP-sensitive potassium channels on beta cell membranes, Glibenclamide triggers membrane depolarisation and calcium-mediated insulin release — increasing circulating insulin availability to drive glucose uptake into cells. Glibenclamide is one of the most potent and longest-acting sulfonylureas, with a duration of action of 16 to 24 hours — providing continuous insulin secretagogue activity across the full dosing interval. The 2.5mg dose delivers clinically meaningful postprandial and fasting insulin stimulation while remaining at a moderate dose where hypoglycaemia risk, though real, is manageable with proper meal timing and glucose monitoring.

Combined Clinical Effect at This Strength: The 500mg Metformin component provides the foundational insulin-sensitising and hepatic glucose-suppressing activity that guidelines recommend as the cornerstone of type 2 diabetes pharmacotherapy, while the 2.5mg Glibenclamide adds the insulin secretagogue activity needed when beta cell function is no longer adequate to maintain glycaemic control on Metformin alone. Together at these doses, the combination typically achieves HbA1c reductions of 1.5 to 2.5% from baseline — placing most patients within reach of their glycaemic target when used with appropriate diet and exercise.

Dosage and Administration

⚠️ Always take with meals — never on an empty stomach. The Glibenclamide component stimulates insulin release regardless of whether food is consumed — skipping a meal after taking Glucovance directly causes hypoglycaemia. Monitor blood glucose regularly. Carry fast-acting glucose at all times. Inform your doctor before any surgery, CT scan with contrast, or procedure requiring fasting or general anaesthesia.

Meal Timing Rules — Critical:

• Take with breakfast for the morning dose and with the evening meal for the second dose
• Never take Glucovance and then delay or skip the meal that follows — hypoglycaemia will result from Glibenclamide's insulin stimulation without corresponding food-driven glucose rise
• If a meal is skipped for any reason, skip the corresponding Glucovance dose and resume with the next scheduled meal

How to Take:

1. Swallow the tablet whole with a full glass of water
2. Take with or immediately after the first bite of a meal
3. Maintain consistent mealtimes to keep blood glucose predictably controlled
4. If a dose is missed and the meal has already passed — skip the missed dose; never double up at the next meal
5. Do not crush or split tablets unless specifically advised

Active Ingredients

Who Should NOT Take Glucovance 500mg/2.5mg?

Do not take Glucovance 500mg/2.5mg if you:

• Have Type 1 Diabetes — not indicated
• Have diabetic ketoacidosis — requires immediate insulin treatment
• Have significant kidney impairment — Metformin accumulates causing lactic acidosis; eGFR must be checked before prescribing and monitored regularly
• Have severe liver disease — both components are contraindicated in significant hepatic impairment
• Are scheduled for surgery under general anaesthesia — stop 48 hours before; restart only after kidney function confirmed normal
• Are having a CT scan or angiogram with iodinated contrast dye — withhold 48 hours before and after
• Have a condition causing tissue hypoxia — severe heart failure, respiratory failure, or recent heart attack
• Have G6PD deficiency — sulfonylureas can cause haemolytic anaemia
• Are allergic to Metformin, Glibenclamide, other sulfonylureas, or any ingredient
• Consume excessive alcohol regularly

Always consult your doctor before use if you:

• Have mild to moderate kidney impairment — dose adjustment and closer monitoring required
• Are elderly — hypoglycaemia risk from Glibenclamide is higher in older patients; slower titration required
• Are pregnant — insulin is standard of care; specialist assessment required
• Are breastfeeding — Glibenclamide may pass into breast milk
• Are taking medicines that interact with sulfonylureas or Metformin — see interactions

Side Effects

Common:

• Hypoglycaemia (شوگر کا گرنا) — the most important side effect; sweating, trembling, dizziness, palpitations, confusion, weakness — risk is higher at 2.5mg Glibenclamide than 1.25mg; always carry fast-acting glucose; risk increases significantly when meals are skipped, alcohol consumed, or physical activity increased without dose adjustment
• Nausea, stomach discomfort, or diarrhoea — Metformin-related; significantly reduced by taking with food
• Metallic taste — Metformin effect; usually fades with continued use
• Weight gain — Glibenclamide-driven insulin secretion promotes fat storage; manage through dietary control
• Mild skin rash or itching — sulfonylurea-related; usually transient

Serious — Seek Emergency Medical Attention Immediately:

• Severe hypoglycaemia — loss of consciousness, seizure, or inability to swallow — administer glucagon or call emergency services; Glibenclamide's prolonged 16 to 24-hour action means hypoglycaemia can persist and recur for many hours — hospital monitoring is often required (یہ طبی ہنگامی صورتحال ہے)
• Lactic acidosis — rare but life-threatening Metformin complication; severe muscle pain, difficulty breathing, stomach pain, feeling cold, slow heartbeat — seek emergency care immediately (یہ طبی ہنگامی صورتحال ہے)
• Severe allergic reaction — rash, swelling of face or throat, difficulty breathing (یہ طبی ہنگامی صورتحال ہے)
• Haemolytic anaemia — rare in G6PD-deficient patients
• Liver effects — jaundice, dark urine, severe fatigue — rare with Glibenclamide

Drug Interactions

Storage Instructions

• Store below 25°C in a cool, dry place
• Protect from moisture and direct sunlight
• Keep in original blister pack until use
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Do not use after the expiry date on the pack or carton

Frequently Asked Questions

How is Glucovance 500mg/2.5mg different from Glucovance 250mg/1.25mg — when does a doctor prescribe this strength?

Glucovance 500mg/2.5mg contains double the Metformin and double the Glibenclamide of the 250mg/1.25mg initiation strength — delivering meaningfully stronger dual-mechanism blood sugar control. Your doctor will prescribe the 500mg/2.5mg strength when the 250mg/1.25mg dose has been tolerated without problems but has not achieved adequate blood glucose and HbA1c targets after 4 to 8 weeks of use. It is also the appropriate strength for patients who are already on separate Metformin 500mg and Glibenclamide 2.5mg tablets and are switching to a single fixed-dose combination for convenience. The higher Glibenclamide dose at this strength means hypoglycaemia risk is greater than with the initiation dose — consistent meal timing and blood glucose monitoring become even more important.

Why is the risk of hypoglycaemia higher with Glucovance 500mg/2.5mg than the lower strength?

The hypoglycaemia risk in Glucovance comes entirely from the Glibenclamide component — Metformin does not cause hypoglycaemia independently. At 2.5mg Glibenclamide, the stimulus for pancreatic insulin secretion is twice as strong as at the 1.25mg initiation dose — producing greater insulin release that can more readily drive blood glucose below normal levels, particularly when a meal is delayed or skipped, physical activity is unexpectedly increased, or alcohol is consumed. Glibenclamide's 16 to 24-hour duration of action means hypoglycaemia can develop hours after the tablet is taken and can persist and recur even after initial treatment — requiring prolonged monitoring after any hypoglycaemic episode. Always carry fast-acting glucose — sugar tablets, glucose sweets, or a small juice carton — whenever you are taking Glucovance.

I am an elderly patient — is Glucovance 500mg/2.5mg safe for me?

Elderly patients can benefit from Glucovance's dual-mechanism blood sugar control but require additional caution at the 500mg/2.5mg strength compared to younger adults. Older patients are at higher risk of hypoglycaemia for several reasons — reduced awareness of early hypoglycaemia warning symptoms, irregular meal patterns, reduced kidney function that slows Glibenclamide clearance prolonging its action, and the use of multiple interacting medications. For elderly patients, doctors often initiate combination therapy at the lower 250mg/1.25mg strength and titrate to 500mg/2.5mg only if tolerated and necessary. If this strength is prescribed, more frequent blood glucose monitoring, strict meal timing, and regular kidney function checks are essential components of safe management.

Can Glucovance 500mg/2.5mg be taken once daily instead of twice daily?

For some patients — particularly those with mild to moderate blood sugar elevation — once-daily Glucovance 500mg/2.5mg with breakfast provides adequate glycaemic control. Twice-daily dosing with breakfast and the evening meal is used when once-daily dosing does not achieve blood glucose targets throughout the full 24-hour period or when postprandial glucose after the evening meal requires specific coverage. Your doctor will prescribe the frequency based on your blood glucose monitoring pattern — fasting glucose, post-breakfast, and post-dinner readings all inform the optimal dosing frequency for your individual situation. Never change your dosing frequency without medical guidance.

What is the difference between Glucovance 500mg/2.5mg and Glucovance 500mg/5mg — which is stronger?

Both tablets contain the same 500mg of Metformin — the Metformin component is identical. The difference is the Glibenclamide dose — 2.5mg versus 5mg. Glucovance 500mg/5mg contains double the Glibenclamide, producing stronger insulin secretagogue stimulation for patients whose blood sugar remains above target on the 2.5mg Glibenclamide strength. The 500mg/5mg strength carries a higher hypoglycaemia risk than 500mg/2.5mg and represents the maximum standard Glucovance dose. The 500mg/2.5mg strength is the intermediate step between the initiation dose and the maximum strength — most patients are titrated through this strength before escalating further if needed.

---

⚕️ Medical Disclaimer: This product description is for general informational purposes only and does not replace professional medical advice. Glucovance is a prescription combination antidiabetic — always use under the supervision of a qualified doctor. Always take with food. Never skip meals after taking this medicine. Carry fast-acting glucose at all times. Stop before contrast procedures and surgery — restart only after medical clearance. Monitor blood glucose regularly.

---

Prescription Required (Rx) | Always Take With Meals — Never Skip | Carry Fast-Acting Glucose at All Times | Stop Before Contrast Procedures & Surgery | Monitor Blood Glucose Regularly | Higher Hypoglycaemia Risk Than 250mg/1.25mg